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Abstract: Alzheimer’s disease is characterized in part by extracellular aggregation of the amyloid-β peptide in the 
form of diffuse and fibrillar plaques in the brain. Electron microscopy (EM) has made an important contribution in 
understanding of the structure of amyloid plaques in humans. Classical EM studies have revealed the architecture 
of the fibrillar core, characterized the progression of neuritic changes, and have identified the neurofibrillary tangles 
formed by paired helical filaments (PHF) in degenerating neurons. Clinical data has strongly correlated cognitive 
impairment in AD with the substantial synapse loss observed in these early ultrastructural studies. Animal models 
of AD-type brain amyloidosis have provided excellent opportunities to study amyloid and neuritic pathology in detail 
and establish the role of neurons and glia in plaque formation. Transgenic mice overexpressing mutant amyloid 
precursor protein (APP) alone with or without mutant presenilin 1 (PS1), have shown that brain amyloid plaque 
development and structure grossly recapitulate classical findings in humans. Transgenic APP/PS1 mice expressing 
human apolioprotein E isoforms also develop amyloid plaque deposition. However no ultrastructural data has been 
reported for these animals. Here we show results from detailed EM analysis of amyloid plaques in APP/PS1 mice 
expressing human isoforms of ApoE and compare these findings with EM data in other transgenic models and 
in human AD. Our results show that similar to other transgenic animals, APP/PS1 mice expressing human ApoE 
isoforms share all major cellular and subcellular degenerative features and highlight the identity of the cellular 
elements involved in Aβ deposition and neuronal degeneration.
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Introduction
Amyloid plaques are a defining feature of 
Alzheimer disease (AD) pathology. AD (senile) 
plaques are composed of extracellular deposits 
of amyloid-β (Aβ) and other plaque associated 
proteins and are surrounded by dystrophic 
neurites and glia. Robert Terry and Michael 
Kidd presented very detailed morphological 
studies of the plaque core, described the 
extensive neuritic changes as well as the 
accumulation of intraneuronal neurofibrillary 
tangles formed by paired helical filaments 
(PHF) [1-5]. In all cases of Alzheimer’s presenile 
dementia, Kidd et al., described the plaque’s 
structure as composed of a “central fibrillar 
core”, “cellular perikarya”, “axons and dendrites 
filled with an excess of neurofibrils”, and “cell 
processes filled with dense bodies” [4]. Almost 
no degenerating neuronal cell bodies were 
identified. In 1973 Wisniewski and Terry 
showed that the earliest sign of plaque 
formation was the appearance of few abnormal 
neurites, followed by “wisps” of deposited 
amyloid [6]. Later EM studies by Yamaguchi et 
al., characterized the structure of the “diffuse 
plaque” with the appearance of small amounts 
of amyloid fibrils and minimal neuritic dystrophy 
[7]. A number of ultrastructural studies in 
humans and also in aging primates documented 
a progressive decrease in synaptic numbers in 
cortical areas including the hippocampus 
[8-10]. Subsequent clinical studies have 
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strongly correlated these findings with cognitive 
decline [11-13]. 
The generation of transgenic (tg) animals as 
models overexpressing mutant human APP 
and/or PS1 and PS2, tg APP mice expressing 
human ApoE isoforms, as well as Tau, has 
made substantial contributions to unraveling 
the diverse CNS changes developing in AD [14-
18]. Tg and other genetically modified animals 
have been invaluable for revealing mechanisms 
of AD neuropathology [19-22], and while no 
mouse model has fully recapitulated the entire 
neuropathological spectrum of AD-like brain 
lesions, they have replicated major pathological 
features such as the diffuse and compact 
amyloid plaque, the massive neuritic dystrophy, 
synaptic deficits, and glial activation [23-26]. 
The first mouse models were based on the 
overexpression of single or multiple mutant 
molecules associated with familial AD (FAD), 
[18]. Masliah et al. in 1996 made a detailed 
comparison of the neurodegenerative 
pathology found in the PDAPP tg mouse line 
and in AD [23]. Although PHF were not found, 
the overproduction of mutant human APP was 
sufficient to cause extensive amyloid fibril 
deposition in the form of diffuse and mature 
amyloid plaques between 8 and 12 months of 
age. Axonal dystrophy, microglial and astroglial 
involvement have been reported as well [23, 
24, 27]. Other APP tg models have all produced 
mature amyloid plaques [28-34]. In APP tg mice 
expressing human mutant forms of APP found 
in FAD, Masliah et al., Phiney et al., and Stalder 
et al., also showed evidence for extensive 
amyloid plaque formation, microglial cell 
process aggregation and a corona of dystrophic 
axons [23, 30, 35]. Interestingly, tg mice 
overexpressing the mutant PS1 alone have not 
been shown to accumulate Aβ in the brain [36] 
while, co-expression of mutant PS1 with APP 
has been always associated with robust 
amyloid deposition months earlier than APP tg 
mice alone. Kurt et al., provided a very detailed 
ultrastructural study on these mice [25]. They 
showed occasional Aβ deposits (plaques) as 
early as two months of age, with deposits 
gradually increasing in number at six months. 
Notably, none of the single transgenic (APP or 
PS1) animals made Aβ deposits at this time-
frame. Electron microscopy characterized two 
main morphological plaque forms, those with 
an Aβ core and those without it. Both forms 
were present at the 12th week. Plaques were 
observed in the neuropil and also in the white 
matter. In mature plaques of 6 and 8 month old 
tg mice, the core was similarly surrounded by 
microglial cell processes; astroglial cell 
processes were also encountered, especially in 
older animals. Neuronal degeneration of the 
non-apoptotic type was registered close to the 
plaque in 8 month old double tg mice. In a 
similar model, Wirths et al., described neuritic 
plaques in the spinal cord and found 
ultrastructural evidence for massive axonal 
degeneration in white matter tracts structurally 
resembling Wallerian type degeneration [37]. 
Triple tg mouse models overexpressing mutant 
APP, PS1 and Tau developed amyloid plaques 
and tangle-like pathology [26, 38]. 
The ε4 allele of apolipoprotein E (ApoE) is 
known so far to be the only firmly established 
risk factor for the more common sporadic forms 
of AD [39]. Astrocyte-specific expression of 
human ApoE3 and E4 isoforms in APP tg mice 
where the mouse apoE has been knocked out, 
restored Aβ and fibrillar Aβ deposition in the 
brain in vivo, suggesting their critical role in 
amyloid deposition with E4 resulting in greater 
Aβ pathology than E3 [40]. Pathways involved 
in ApoE and/or Aβ clearance have shown that 
overexpression of the low density lipoprotein 
receptor markedly inhibits in vivo amyloid 
deposition and in addition increases Aβ 
clearance [41]. However to date there are no 
ultrastructural studies to complement the light 
microscopic and functional data from tg 
animals expressing human apoE and no EM 
comparison is available with other models or 
AD. The aim of the current study is to provide a 
detailed ultrastructural investigation of amyloid 
plaques in APP/PS1 tg mice expressing each 
one of the three human apolipoprotein iso-
forms (ApoE2, ApoE3 or ApoE4) and to com-
pare the neuritic plaque morphology to other 
existing tg animal models of AD.
Material and methods
Generation of human APOE isoform mice with 
APPswe/PS1(L166P) mutant transgenes
To determine the effect of human APOE2, 
APOE3 and APOE4 on amyloid deposition, we 
used APOE knock-in mouse models in which 
the endogenous murine APOE gene is replaced 
with the human APOE2, APOE3 or APOE4 gene. 
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The generation of human APOE2, APOE3 and 
APOE4 knock-in mouse models has been 
reported previously and breeding pairs were 
gifts from Dr. Patrick Sullivan (Duke Universtity) 
more APPPS1-21/APOE3/3 mice. After suc-
cessful generation of APPPS1-21/APOE3/3 
mice at the third generation, APPPS1-21/
APOE3/3 mice were bred with APOE knockout 
[42, 43]. APOE isoform mice were main-
tained on a C57BL/6J background. 
APPPS1-21 mice overexpress a human 
APP with Swedish mutation 
(KM670/671NL) and PS1 with L166P 
mutation under the control of Thy1 pro-
moter. Breeding pairs were obtained as a 
gift from Dr. Mathias Jucker (University of 
Tubingen) [44]. To replace the murine 
APOE (mAPOE) gene with human APOE 
isoforms, we recently described the pro-
duction of APPPS1-21/APOE knockin 
mice [45]. Briefly, APPPS1-21 mice were 
bred with APOE2/2, APOE3/3 or APOE4/4 
knock-in mice. For example, APPPS1-21/
APOE3/mAPOE mice and APOE3/mAPOE 
mice from the first generation were bred 
with each other to generate APPPS1-21/
APOE3/3 and APOE3/3 mice. APPPS1-
21/APOE3/3 and APOE3/3 mice from the 
second generation were bred to generate 
Figure 1. Low and high magnification images of plastic sections showing cortical plaques in APP/PS1/Human ApoE 
knock-in tg mice. A and D – APP/PS1/ApoE2, B and E - APP/PS1/ApoE3, C and F - APP/PS1/ApoE4 tg mice. Scale 
bar: A, B and C – 100 µm; D, E and F – 20 µm. 
Figure 2. Panoramic view of a mature amyloid plaque in APP/
PS1/ApoE4 tg mouse. Single black asterisks show processes 
of microglial cells surrounding the core epicenter, double as-
terisks show an astrocytic process. Scale bar – 5 µm.
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(APOE-/-) mice on a C57BL/6J background 
(Stock number 002052, The Jackson 
Laboratory) [46]. APPPS1-21/APOE3/- mice 
from the fourth generation were bred with 
APOE3/3 mice to generate APPPS1-21/
APOE3/3 mice. Littermates generated at the 
fifth generation were analyzed for Aβ accumula-
tion, amyloid deposition, and microgliosis. 
Similarly, APPPS1-21/APOE2/2 and APPPS1-
21/APOE4/4 mice were generated by five gen-
erations of breeding using the same mating 
strategy. All mice used in this study were main-
tained on a C57BL/6J background.
Transmission electron microscopy
Six months old mice (3 from each isoform-spe-
cific type and 3 age matched controls) were 
anesthetized with pentobarbital and perfused 
transcardially with a fixative composed of 1.5% 
glutaraldehyde and 1% paraformaldehyde in 
0.1 M cacodylate buffer (pH 7.4). The brains 
were sliced into 1-mm-thick coronal sections 
and fixed for 24 hrs in 1.5% glutaraldehyde and 
then rinsed in cacodylate buffer. Sections were 
postfixed overnight in 1% osmium tetroxide. 
Tissue was dehydrated in graded solutions of 
ethanol from 40% to 100% (each for 10 min), 
cleared in propylene oxide, and flat-embedded 
in araldite. Ultrathin sections were cut with a 
Leica Ultracut UCT ultramicrotome. Sections 
were counterstained with saturated aqueous 
uranyl acetate, followed by lead citrate and 
analyzed with a JEOL 100CX transmission elec-
tron microscope.
Results
Overview of amyloid plaques
Investigation of semithin sections in all APP/
PS1/HumanApoE knock-in animals revealed 
the presence of cortical (Figure 1) and subcorti-
Figure 3. Electron micrograph showning microglial cell processes with numerous invaginations (infoldings). Infold-
ings contain bundles of amyliid fibrils (*). Inset in A. shows fibrils at higher magnification (arrow). B. Amyloid fibril-
filled infoldings (*) seen very close to the RER (arrows) of a microglial cell. C. Microglial cell nuclear region (*) close 
to dystrophic myelinated neurite (DN). Scale bars: A and B  - 0.3µm; C - 1 µm.
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cal plaques. In all 6 months old APP/PS1/
HumanApoE knock-in mice, the vast majority of 
amyloid plaques fell in the category of the 
mature plaque. Ultrastructurally no gross mor-
phological difference was detected between 
the three different knock-in transgenes, except 
that in APP/PS1/HumanApoE2 and E3 knock-in 
brains plaques had smaller core centers. 
Amyloid plaque epicenter
Ultrastructural investigation of amyloid plaques 
in ApoE2, ApoE3 and ApoE4 knock-in mice 
revealed that all mature plaques were repre-
sented by an epicenter of compacted Aβ fibrils, 
most of which were organized in parallel radial 
bundles giving the core a star-shape outline 
(Figure 2). In some, fibril 
bundles surrounded dark 
irregular and highly 
osmiophilic structures, 
probably representing 
terminally dystrophic cell 
processes (not shown). At 
high magnifications indi-
vidual fibrils contained 
hollow lumina (Figure 3A, 
inset). Very rarely axonal 
terminals with small clear 
vesicles were observed 
(not shown), but in gener-
al, the core epicenter was 
surrounded by microglial 
cell processes (Figure 2 
asterisks). Rarely single 
dystrophic myelinated 
axons and dystrophic 
dendritic profiles were 
observed. 
Microglial cells and their 
processes surround the 
amyloid plaque core
The immediate periphery 
of the plaque epicenter 
was surrounded by a 
crown of microglial cyto-
plasmic processes 
(Figure 2, single aster-
isks). These processes 
typically contained short 
cisternae of rough endo-
plasmic reticulum (RER) 
as well as free ribosomes 
(Figure 3B). A microglial cell nuclear region was 
very rarely observed (Figure 3C). The identifica-
tion of microglial cells and their processes was 
made by their specific EM appearance and also 
after careful comparison of our data to images 
presented by Mattiace et al., and Stalder et al., 
where detailed EM immunohistocheimical char-
acterization of these cells and their long pro-
cesses has been presented [47, 35]. Virtually 
all microglial cell processes had numerous 
invaginations filled by amyloid fibrils (Figure 3 
asterisks, Figure 3A inset). Many of these fibril-
filled spaces were very close to cisternae of 
RER (Figure 3B arrows). Lysosomes and pha-
golysosomes were frequently detected in these 
processes, while others were filled with debris 
Figure 4. A. Electron micrograph showing processes of activated microglia 
exhibiting phagocytosis. Note also the deep invaginations filled with amyloid 
fibrils. Arrows point to lysosomes. B. Microglial process with internalized seg-
ment of a dystrophic myelinated axon (arrow). C. Microglial cell process with 
phagocytozed cellular debris (arrows). Scale bar: A and C – 500 nm, B – 1.5 
µm. 
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from surrounding dystrophic neurites (Figure 
4). Amyloid fibrils were arranged in loose paral-
lel arrays similar to those detected by others in 
early diffuse plaques, other plaque deposits 
resembled a fibrillar lattice. The plaque core 
contained few astroglial cell processes as well 
(Figure 2), which in general had a lighter cellu-
lar matrix compared to microglial cells, and 
were devoid of rough endoplasmic reticulum 
and typically contained slender intermediate 
filament bundles (not shown). 
Immediate periphery of the plaque core: numerous 
dystrophic neurites
All mature plaques presented with numerous 
dystrophic neurites with dense bodies and 
vacuoles filled with lamellar material. They were 
found predominantly in the immediate 
periphery surrounding the microglial processes 
(Figures 2, 3, 4 and 5). The majority were in an 
advanced stage of degeneration (Figure 5C-I). 
Almost all were non-myelinated (Figure 2 and 
5). Neuritic processes with signs of mild 
dystrophy contained combinations of clear 
synaptic vesicles and few large dense core 
vesicles, in others normal single or multiple 
mitochondria were also observed (Figure 5A). 
Profiles showing moderate signs of dystrophy 
exhibited autophagic vacuoles filled with 
lamellar material and/or degenerating 
mitochondria (Figure 5A inset 5C). A number of 
degenerating mitochondria were frequently 
Figure 5. Electron micrographs showing dystrophic neurites at different stages of degeneration; A and B – early 
stage, C – mid stage, D-H - late stage. Asterisk in A shows accumulation of normal mitochondria, inset in addition 
shows degenerating mitochondrion (arrow) and autophagic vacuoles. Asterisk in G shows a dystrophic neurite 
with very condensed axoplasmic matrix and accumulation of autophagic vacuoles. Autophagic vacuoles are also 
abundant in D, E, F, H. Micrograph in I shows a neurite (*) in very advanced stage of dystrophy with no limiting 
cytoplasmic membrane (arrows). Scale bars: – 500 nm.
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Figure 6. Micrographs of axonal terminals at different stages of degeneration 
showing morphologically normal synapses. A. Moderately degenerated terminal 
(arrow) and non-degenerated terminal (double arrow) synapsing on the same den-
dritic shaft (*), APP/PS1/ApoE3 tg mouse. B. Grossly degenerated axonal terminal 
synapsing on a normal dendritic spine (*), APP/PS1/ApoE4 tg mouse. C. Grossly 
degenerated axonal terminal synapsing on a dendritic spine (*) showing a normal 
mitochondrion (m), APP/PS1/ApoE2 tg mouse. Even at this high magnification no 
abnormal features in the structure of the synaptic membranes are observed. Scale 
bars: – 1 µm.
seen in profiles with developed dystrophy, 
where lysosomes were also identified (Figure 
5A inset, 5B and 5C). In neuritic processes with 
more advanced degeneration there were abun-
dant autophagic vacuoles, phagolysosomes 
and virtually no normal organelles (Figure 
5D-H). In a number of neuritic processes we 
were not able to detect a continuous cytoplas-
mic membrane (Figure 5I, asterisk) and bor-
ders between these processes and the neigh-
boring neuropil was not discernable (Figure 5I, 
arrows). Occasionally single Hirano-like bodies 
were observed in dystrophic profiles (Figure 9). 
Interestingly we were also able to detect a num-
ber of dystrophic processes, which maintained 
morphologically distinct synapses on seeming-
ly intact dendritic spines or shafts (Figure 
6A-C). They were identi-
fied as axonal termi-
nals. While the degree 
of degeneration in 
these terminals varied, 
in all, the pre-synaptic 
and post-synaptic den-




(Figure 6B and 6C, 
asterisk). As in areas 
close to the plaque epi-
center, in the immedi-
ate plaque periphery of 
all transgenic animals 
we detected a number 
of dystrophic myelinat-
ed axonal profiles with 
compacted organelles 
and thinning of the 
myelin sheath (not 
shown), in others there 
was a visible transition 
from a myelinated to a 
non-myelinated seg-
ment (Figure 7A). 
Swollen axonal profiles 
with compaction of 
neurofilaments and 
signs of dystrophy and 
edema of the oligoden-
drocytic cytoplasm was 
also observed (Figure 
7C, asterisks), in others 
a corona of compacted 
neurofilaments surrounding a center of organ-
elle compaction was frequently detected 
(Figure 7D). 
Wider periphery of the plaque core and white 
matter
In areas very close to cortical or hippocampal 
plaques, single degenerating neuronal cell peri-
karya and their dendrites revealing very elec-
tron dense nuclear and cytoplasmic matrices, 
were frequently observed (Figure 8A and 8B). 
However no apoptotic morphology was detect-
ed in these degenerating neurons. The cyto-
plasm of these dying cells was filled with dense 
fibrillar material (Figure 8C, 8D and 8E) and in 
many cases cytoplasmic membranes were not 
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visible. In the latter cases amyloid fibrils were in 
direct apposition to the extracellular matrix 
(Figure 8E, arrows). Careful examination of 
cross and longitudinal sections through the 
major white matter tracts such as the external 
capsule and the axonal bundle of stratum lacu-
nosum in the hippocampus and hippocampal 
commisure revealed many single dystrophic 
myelinated and non-myelinated axons. Many 
myelinated axons showed dystrophic features 
similar to Wallerian degeneration (Figure 7B), 
while others showed similar degeneration 
changes seen in dystrophic plaque neurites. 
Discussion
In this study, the compact amyloid epicenter 
(core), the dystrophic cellular elements directly 
adjacent or close to the amyloid core were 
examined at the ultrastructural level in APP/
PS1 tg mice expressing one of the three human 
ApoE isoforms - ApoE2, ApoE3 and ApoE4 
respectively. 
The plaque epicenter was almost exclusively 
occupied by amyloid fibrils and largely devoid of 
cellular elements. We found that the amyloid 
fibrillar star’s periphery resided within deep 
cytoplamic infoldings of microglial cell process-
es which separated the amyloid epicenter from 
the dystrophic neuropil surrounding it. This 
plaque architecture is similar to many other 
mouse models [23, 25, 35, 48-50]. The exis-
tence of a microglial core periphery was not 
surprising, since animal studies have shown 
that microglial response around plaques occurs 
Figure 7. A. Micrograph showing a transition from a myelinated (white arrow) to a non-myelinated (black arrow) 
segment in a longitudinally sectioned axonal profile.  B. Micrograph showing a white matter myelinated axon with 
morphological signs of degeneration of the Wallerian type. C. Micrograph showing a swollen axonal profile with 
compaction of neurofillaments and edema of the olygodendrocitic cytoplasm (asterisks); arrow pointing to the node 
of Ranvier.  D. Micrograph of a very swollen myelinated axon - a corona of compacted neurofilaments surrounds a 
center of organelle aggregation. Scale bar: A – 1 µm, B, C and D – 2 µm. 
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often and relatively soon [51, 52]. Historically, 
in many human and animal studies the relation-
ship between amyloid deposition/turnover and 
microglia has been discussed in great detail [2, 
23, 25, 35, 48-50, 53-55] and is beyond the 
scope of this study. Nevertheless it has to be 
noted that to date this relationship remains 
poorly understood although many have argued 
that microglia cells may also be considered to 
be a driving force in depositing or clearing fibril-
lar amyloid [54, 56-58]. Interestingly, after 
careful ultrastructural 
examination of serial sec-
tions with subsequent 
3-dimentional amyloid 
plaque reconstruction of 
APP23 tg mouse brains, 
no evidence of amyloid 
phagocytosis and/or amy-
loid secretion by microglia 
has been detected [48]. In 
addition, Grathworth et 
al., in an elegant and well 
designed in vivo study, 
have shown that the for-
mation and maintenance 
of the amyloid plaque can 
occur in almost complete 
absence of microglia and 
that neuritic dystrophy is a 
process that may develop 
independent of microglia 
[59]. 
Although smaller in num-
ber, we were able to 
observe astrocytic pro-
cesses in the plaque core, 
some of them filled with 
phagocytosed debris simi-
lar to that of microglia. 
Various ultrastructural 
studies have detected 
astrocytic processes in 
human AD plaques [23, 
57], and were also shown 
to exhibit β-amyloid immu-
noreactivity with gold 
probes [45]. Although we 
were not able to clearly 
distinguish between dor-
mant and hypertrophic 
astroglia, their constant 
presence around the 
plaque epicenter and around dystrophic axons 
warrants further investigation. 
Similar to single APP tg, double APP/PS1 tg and 
triple APP/PS1/Tau tg mice [23, 25, 26, 30, 
60], our studies revealed numerous neuritic 
profiles at different stages of swelling and 
degeneration which surrounded the microglial 
processes ring. Surviving synaptic figures in 
many of these dystrophic profiles argue in favor 
of the interpretation that the majority of the 
Figure 8. Micrographs of degenerating neuronal cell bodies (A and B) and neuro-
nal cell processes (C, D and E) revealing grossly condensed matrices. Asterisks 
show accumulation of amyloid fibrils in the dystrophic cytoplasm of degenerating 
cells. Arrow in E indicates an interface between a degenerating cell process and 
the surrounding neuropil where the cell membrane is not detected and amyloid 
fibrils can be identified. E is a high magnification of D rotated at 90°. Scale bars 
– A and B -1 µm, C, D and E – 1 µm.
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dystrophic neurites surrounding amyloid 
plaques are axonal (presynaptic) in origin. 
These suggestions are supported also by the 
fact that many single neuritic profiles close to 
the amyloid territory, and showing exactly the 
same dystrophic morphology, were myelinated. 
Importantly, they were very frequently seen in 
the white matter plaques as well and argue in 
favor of long axon degeneration. Likewise, 
many EM studies in AD [12, 62] support the 
predominant axonal origin of the plaque’s dys-
trophic neurites. 
We also found that degenerating axons under-
go extensive cytoskeletal changes in addition 
to the compaction of normal and dystrophic 
organelles. Similar alterations have been 
observed in APP tg mice, in tg mice with human 
four-repeat tau proteins and in mice expressing 
mutant human tau [23, 25, 30, 61, 63-65]. 
Early extracellular Aβ deposits in transgenic 
mice expressing wild-type human tau have 
shown to induce increased tau phosphorylation 
and coexisted with neuritic and cytoskeletal 
pathology that was strikingly similar to our 
observations [61]. The above studies have also 
concluded that a long exposure to Aβ in vivo is 
insufficient to drive the formation of PHF. At the 
same time double tg mice lacking the human 
APP transgene failed to develop extracellular 
plaques, no intracellular Aβ immunoreactivity 
was found and no physiological features of 
synaptic dysfunction was recorded [26]. Axonal 
swelling and accumulation of dystrophic 
organelles, such as mitochondria and 
autophagic vacuoles and the apparent 
cytoskeletal pathology, while indicative of 
progressive axonal degeneration, may also 
represent gross disturbances in anterograde or 
retrograde transport [61, 65, 66]. Changes in 
the axoplasmic cytoskeleton in association 
with organelle compaction has been 
consistently observed by us and others after 
experimental traumatic brain injury [67-69] and 
these features have been classically interpreted 
as axonal transport impairment [70]. In APP/
PS1 human ApoE isoform knock-in animals, we 
have consistently encountered similar changes 
in long fiber tract axons. The latter exhibited not 
only “classical” plaque neuritic pathology, but 
in addition dystrophic changes similar to the 
Wallerian type of axonal degeneration, a 
phenomenon observed also by Wirths et al., in 
the spinal cord in APP/PS1 tg mice [37] as well 
as in AD [1]. Impaired axonal transport appears 
to be a major pathological alteration in later 
stages of the AD progression in humans and 
the axonal pathology described by us and oth-
ers recapitulates the cardinal features of axo-
nal impairment and possible chronic deficits. 
Hirano bodies have been observed in some 
cases of AD, amyotrophic lateral sclerosis/par-
kinsonism-dementia complex of Guam and in 
many tg models [23, 61, 71]. Different studies 
indicate the presence of actin, tropomyosin 
and vinculine [72, 73] but currently, Hirano 
body formation is considered to be a non-spe-
cific lesion in AD-type neuropathologies and is 
thought to reflect alterations of the actin net-
work in dystrophic axons [71]. Our studies, in 
agreement with other studies in tg animals, 
found no evidence of PHF. 
As in APP/PS1 tg animals, APP/PS1/Human 
ApoE knock-in mice which develop mature amy-
loid plaques reveal a number of neurons which 
show classical EM signs of non-apoptotic cell 
death. However, at this postnatal age, no indi-
cation of autophagic or apoptotic cell death has 
been detected ultrastructurally, although many 
axonal processes exhibited a pathology consis-
Figure 9. Hirano body (HB) in a dystrophic neurite (*). 
Inset shows many equally spaced parallel filaments 
seen in the HB. Scale bar – 500 nm.
Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms
492 Int J Clin Exp Pathol 2012;5(6):482-495
tent with the engagement of autophagic vacu-
oles. Our data are similar to data from APP/PS1 
tg mice where the lysosomal pathology was 
prevailing in degenerating neurons of older ani-
mals [25, 74]. In our single time-point study, it is 
difficult to argue that axonal pathology and neu-
ronal cell death are directly related since we 
have found much less neuronal cell body 
degeneration compared to the massive axonal 
dystrophy throughout the brain and especially 
within the neuritic plaque. Nonetheless, non-
apoptotic type of cell death can be substantial 
given the protracted nature of the pathology 
observed in these animals. Mitochondrial dys-
function and oxidative stress in degenerating 
neurites as causative factors for the progres-
sive cell death occurring in APP/PS1 tg animals 
has also been discussed [75]. Although apopto-
sis has been implicated in the neuronal cell 
death in aging APP/PS mice [75, 76] based on 
a number of activated caspase 3 immunoreac-
tive cells and ultrastructural morphology 
(believed to be the best morphological method 
for distinguishing apoptosis from other types of 
neuronal cell degeneration), the involvement of 
this cell death type in tg animals remains uncer-
tain [77]. The involvement of apoptotic cell 
death is also unclear in human AD cases [78]. 
Implicating the potential role of autophagic 
neuronal cell death, Yang et al., have presented 
evidence for a cross talk between apoptosis 
and autophagy by showing robust activated 
caspase 3 staining in autophagic vacuoles in 
dystrophic neurites of APP/PS1 tg mice [76]. 
Interestingly, in AD brains certain hippocampal 
neurons have also shown features of granulo-
vacuolar degeneration with the expression of 
activated caspase 3 [79]. Taken together these 
findings reinforce the idea of possible connec-
tion between elements of apoptotic and 
autophagic degeneration in some experimental 
models, and also in cases of AD. However, fur-
ther investigation is needed to resolve this 
issue. 
In summary, our studies show that like in senile 
primate AD models, single tg APP mice, double 
tg APP/PS1 mice, and triple tg APP/PS1/Tau 
mice, APP/PS1 mice expressing human ApoE 
isoforms develop mature neuritic plaques with 
similar ultrastructural components and share 
the cardinal features of the senile plaque. 
Therefore this model may be useful for the 
study of AD pathogenesis and treatment strate-
gies in the context of human ApoE isoforms.
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